16:02 EDT Actuate Therapeutics (ACTU) files to sell 1.33M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACTU:
- Promising Clinical Developments and Valuation Support Buy Rating for Actuate Therapeutics
- Actuate Therapeutics announces end of Phase 1 portion of elraglusib study
- Actuate Therapeutics Secures $4.7M in Private Placement
- Actuate highlights results from subgroup analysis of Phase 2 elraglusib trial
- Actuate reports biomarker, machine learning data from Phase 2 elraglusib trial